The DOI matches its Crossref record.
Vasostatins, Comprising the N‐terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments
Abstract
Chromogranin A (CGA) belongs to a family of highly acidic proteins which are co‐stored and co‐released with the catecholamines from the mammalian adrenal gland and occur in nmolar concentrations in the human circulation. A vascular function for the adrenomedullary released and circulating CGA has yet to be established. The present study reports on the novel vasoinhibitory effect of the N‐terminal domain of the adrenomedullary CGA in isolated segments of the human internal thoracic artery (ITA) and saphenous vein (SV). The collective term vasostatin(s) refers to N‐terminal fragments (CGA 1–76 and CGA 1–113) of apparent molecular weights 7 to 22 kD, to indicate their vascular inhibitory effects. The sustained contractions evoked by the potent vasoconstrictor peptide, endothelin‐1 (ET‐1) were suppressed when ITA and SV segments were preincubated for 15 min with vasostatins (72 nM). The vasoinhibitory effects were not dependent on an intact endothelium and suppression of the response to 35 nM ET‐1 was ∼77% and ∼40% in endothelium‐denuded ITA and SV segments, respectively. In endothelium‐denuded SV segments the vasostatins suppressed the maximal sustained tension response but not the potency for ET‐1, indicating that the vasostatin effect did not involve interference with ET‐1 binding to its vascular receptor. Preincubation of endothelium‐denuded SV segments with nifedipine (1 μM) inhibited the sustained response to ET‐1 ≥10 nM by 50%. By the same protocol a 20 to 40% suppression of the contraction evoked by ET‐1 ≥10 nM was obtained in segments preincubated with vasostatins (72 nM), suggesting that inhibition of Ca 2 channel opening might indirectly contribute to the effect of vasostatins on the sustained response to ET‐1. The mechanisms for these inhibitory effects of vasostatins on the sustained ET‐1 contractions in human blood vessels remain to be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
The Extended Granin Family: Structure, Function, and Biomedical Implications
Bartolomucci, A., Possenti, R., Mahata, S. K., Fischer-Colbrie, R., Loh, Y. P., & Salton, S. R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0027 · Cited by 348
Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog
Mahapatra, N. R., O’Connor, D. T., Vaingankar, S. M., Hikim, A. P. S., Mahata, M., Ray, S., Staite, E., Wu, H., Gu, Y., Dalton, N., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24354 · Cited by 309
Marotta, V., Zatelli, M. C., Sciammarella, C., Ambrosio, M. R., Bondanelli, M., Colao, A., & Faggiano, A. (2018) · Endocrine-Related Cancer · doi:10.1530/erc-17-0269 · Cited by 161
Pasqua, T., Mahata, S., Bandyopadhyay, G. K., Biswas, A., Perkins, G. A., Sinha-Hikim, A. P., Goldstein, D. S., Eiden, L. E., & Mahata, S. K. (2016) · Cell and Tissue Research · doi:10.1007/s00441-015-2316-3 · Cited by 53
“…et al. 2015; Gayen et al. 2009b; Sanchez-Margalet et al. 2010; Tatemoto et al. 1986), the vasodilating and cardioprotective vasostatin (Aardal et al. 1993; Tota et al. 2008), the anti-adrenergic (Mahata et al. 2003; Mahata, et al. 2010; Mahata et al. 1997), anti-hypertensive…”
Metadata
- Authors
- Aardal, S., Helle, K. B., Elsayed, S., Reed, R. K., & Serck‐Hanssen, G.
- Venue
- Journal of Neuroendocrinology
- Publisher
- Wiley
- Published
- 1993-08
- Volume
- 5
- Issue
- 4
- Pages
- 405-412
- ISSN
- 0953-8194 (ISSN-L)
- 1365-2826
- OpenAlex
- W1978290925
- Cited by
- 185
- References
- 0
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasostatins, Comprising the N‐terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments. https://app.cochat.ai/papers/10.1111/j.1365-2826.1993.tb00501.x
- The paper
- Aardal, S., Helle, K. B., Elsayed, S., Reed, R. K., & Serck‐Hanssen, G. (1993). Vasostatins, Comprising the N‐terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments. Journal of Neuroendocrinology. https://doi.org/10.1111/j.1365-2826.1993.tb00501.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.